Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NTBL

Notable Labs (NTBL) Stock Price, News & Analysis

Notable Labs logo

About Notable Labs Stock (NASDAQ:NTBL)

Key Stats

Today's Range
$0.25
$0.25
50-Day Range
$0.24
$0.48
52-Week Range
$0.22
$4.24
Volume
N/A
Average Volume
1.01 million shs
Market Capitalization
$2.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.

Receive NTBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Notable Labs and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NTBL Stock News Headlines

Notable Labs, Ltd. (NTBLQ)
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
Notable Labs (NTBL) was downgraded to a Hold Rating at JMP Securities
Notable Labs to Present Data on September 4th at SOHO 2024
Notable Labs Announces CEO Transition
NTBL Stock Earnings: Notable Labs Misses EPS for Q2 2024
See More Headlines

NTBL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Notable Labs investors own include Algonquin Power & Utilities (AQN), LiveOne (LVO), Palatin Technologies (PTN), Frontier Group (ULCC), Adverum Biotechnologies (ADVM), Sirius XM (SIRI) and Clearside Biomedical (CLSD).

Company Calendar

Today
8/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:NTBL
Previous Symbol
NASDAQ:NTBL
CIK
1603207
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.26 million
Net Margins
N/A
Pretax Margin
-3,368.05%
Return on Equity
-80.81%
Return on Assets
-62.86%

Debt

Debt-to-Equity Ratio
0.03
Current Ratio
2.77
Quick Ratio
2.77

Sales & Book Value

Annual Sales
$313 thousand
Price / Sales
7.14
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.81 per share
Price / Book
0.04

Miscellaneous

Outstanding Shares
9,018,000
Free Float
9,544,000
Market Cap
$2.24 million
Optionable
No Data
Beta
0.98
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:NTBL) was last updated on 8/22/2026 by MarketBeat.com Staff.
From Our Partners